CharlesRCaginDO
Cardiology • La Crosse, WICardiac Electrophysiology, Interventional Cardiology
Cardiologist and Assistant Professor
Dr. Cagin is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
800 West Ave S
La Crosse, WI 54601Phone+1 608-392-9862Fax+1 608-392-7881- Is this information wrong?
Summary
- Dr. Charles Cagin is a cardiologist in La Crosse, WI and is affiliated with multiple hospitals in the area, including Mayo Clinic Hospital - Rochester and Mayo Clinic Health System - Franciscan Healthcare in Sparta. He received his medical degree from Des Moines University College of Osteopathic Medicine and has been in practice 43 years. He specializes in interventional cardiology and is experienced in valvular heart disease, cardiac catheterization, cardiac critical care, and icd / pacemaker insertion.
Education & Training
University of ToledoFellowship, Cardiovascular Disease, 1977 - 1979
Mount Sinai Hospital Medical Center of ChicagoResidency, Internal Medicine, 1975 - 1977
University at BuffaloInternship, Internal Medicine, 1974 - 1975
Des Moines University College of Osteopathic MedicineClass of 1974
Certifications & Licensure
IA State License 1979 - 2025
WI State License 2003 - 2025
MN State License 2003 - 2024
IL State License 1976 - 2002
OH State License 1977 - 1979- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Cardiovascular Disease
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
Clinical Trials
- Tailored Antiplatelet Therapy Following PCI Start of enrollment: 2013 May 01
Publications & Presentations
PubMed
- Digital Tool-Assisted Hospitalization Detection in the Tailored Antiplatelet Initiation to Lessen Outcomes due to Decreased Clopidogrel Response After Percutaneous Cor...Robert Avram, Julia Byrne, Derek So, Erin Iturriaga, Ryan Lennon, Vishakantha Murthy, Nancy Geller, Shaun Goodman, Charanjit Rihal, Yves Rosenberg, Kent Bailey, Michae...> ;Journal of Medical Internet Research. 2023 Nov 10
- 3 citationsDiagnosis and Prognosis of Type 2 Myocardial Infarction Using Objective Evidence of Acute Myocardial Ischemia: A Validation Study.Jonathan D Knott, Laura De Michieli, Olatunde Ola, Ashok Akula, Ramila A Mehta, David O Hodge, Tahir Tak, Charles Cagin, Rajiv Gulati, Allan S Jaffe, Yader Sandoval> ;The American Journal of Medicine. 2023 Jul 1
- 5 citationsMajor adverse cardiovascular events after diagnosis of myocardial injury and types 1 and 2 myocardial infarction.Jonathan D Knott, Olatunde Ola, Laura De Michieli, Ashok Akula, Ramila A Mehta, Marshall Dworak, Erika Crockford, Ronstan Lobo, Nicholas Rastas, Swetha Karturi, Scott ...> ;European Heart Journal. Acute Cardiovascular Care. 2022 Jul 21
- Join now to see all
Journal Articles
- Effect of Genotype-Guided Oral P2Y12 Inhibitor Selection vs Conventional Clopidogrel Therapy on Ischemic Outcomes After Percutaneous Coronary InterventionNaveen L Pereira, Verghese Mathew, Charles Cagin, Amir Lerman, Charanjit Rihal, JAMA
Authored Content
- Effect of Genotype-Guided Oral P2Y12 Inhibitor Selection vs Conventional Clopidogrel Therapy on Ischemic Outcomes After Percutaneous Coronary InterventionAugust 2020
- Effect of Genotype-Guided Oral P2Y12 Inhibitor Selection vs Conventional Clopidogrel Therapy on Ischemic Outcomes After Percutaneous Coronary InterventionAugust 2020
Professional Memberships
- Member
Hospital Affiliations
Mayo Clinic Hospital - RochesterRochester, Minnesota- Mayo Clinic Health System - Franciscan Healthcare in La CrosseLa Crosse, Wisconsin
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
